Theseus Pharmaceuticals, Inc.
THRXDelisted Feb 14, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001745020
Theseus Pharmaceuticals, Inc. was delisted on Feb 14, 2024; its insiders filed their last Form 4 on Feb 14, 2024; 70 institutions reported holding it in 13F filings for Q4 2023, worth $145.8M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Theseus Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 47 | 1 | 51 | +5 |
| Shares | 35.0M | 1.67K | 34.7M | −291.9K (−0.8%) |
| Value | $402.8M | $19.0K | $191.6M | −$211.1M (−52.4%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Theseus Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Opaleye Management Inc. | 32,300 | $179.0K | 0.08% |
| Walleye Capital LLC | 31,719 | $175.0K | 0.01% |
| Rhumbline Advisers | 23,405 | $129.0K | 0.00% |
| Susquehanna International Group, LLP | 22,402 | $124.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 10,412 | $58.0K | 0.00% |
| Credit Suisse AG | 14 | $0 | 0.00% |
| Castle Wealth Management LLC | 50 | $0 | 0.00% |
Sold out (2)
Institutions that held Theseus Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Adage Capital Partners GP, L.L.C. | 761,589 | $8.78M |
| UBS Group AG | 2,041 | $24.0K |
Not filed for Q2 2022 yet (1)
Institutions that held Theseus Pharmaceuticals, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 1,670 | $19.0K |